The trial has enrolled a total of 1,832 patients and designed to evaluate the safety and effectiveness of the MagicTouch Sirolimus-Coated Balloon (SCB) in comparison with the Everolimus-Eluting Stent (EES) in patients with De-Novo Coronary Artery Disease.
Study evaluating efficacy of Sirolimus-Coated Balloon against Drug-eluting Stent completes patient enrollment
Empire Heights Tower, 8th floor, Dubai.
Email: contact@globalsupportcare.com
For Emergency: +447488891811
  Empire Heights Tower, 8th floor, Dubai.        Email: contact@globalsupportcare.com            For Emergency: +447488891811
